Advertisement
Canada markets close in 2 hours 46 minutes
  • S&P/TSX

    22,308.90
    -66.93 (-0.30%)
     
  • S&P 500

    5,215.13
    +1.05 (+0.02%)
     
  • DOW

    39,474.27
    +86.51 (+0.22%)
     
  • CAD/USD

    0.7314
    +0.0003 (+0.04%)
     
  • CRUDE OIL

    78.39
    -0.87 (-1.10%)
     
  • Bitcoin CAD

    83,085.98
    -1,605.77 (-1.90%)
     
  • CMC Crypto 200

    1,264.98
    -93.03 (-6.85%)
     
  • GOLD FUTURES

    2,375.00
    +34.70 (+1.48%)
     
  • RUSSELL 2000

    2,058.88
    -14.76 (-0.71%)
     
  • 10-Yr Bond

    4.5060
    +0.0570 (+1.28%)
     
  • NASDAQ

    16,316.77
    -29.49 (-0.18%)
     
  • VOLATILITY

    12.73
    +0.04 (+0.32%)
     
  • FTSE

    8,433.76
    +52.41 (+0.63%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • CAD/EUR

    0.6785
    +0.0007 (+0.10%)
     

Investors Are Jumping the Gun on Moderna's Vaccine Results

Investors Are Jumping the Gun on Moderna's Vaccine Results

Shares of Moderna (NASDAQ: MRNA) were soaring earlier this month when the company released interim results from its mRNA vaccine. Investors were bullish on the possible COVID-19 vaccine, sending the stock to an all-time high of $87. Coronavirus stocks like Moderna are especially volatile surrounding news related to any treatments or vaccines.